Neurocrine Biosciences reported $485.1M in Current Liabilities for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
Acadia Pharmaceuticals ACAD:US USD 116.57M 1.11M
Agios Pharmaceuticals AGIO:US USD 53.6M 5.2M
ALKERMES ALKS:US USD 469.56M 31.04M
Alnylam Pharmaceuticals ALNY:US USD 772.79M 115.11M
Amgen AMGN:US USD 14.33B 1.71B
Aptinyx Inc APTX:US USD 2.69M 2.99M
Biogen BIIB:US USD 3.93B 1.09B
Biomarin Pharmaceutical BMRN:US USD 521.02M 56.29M
Cytokinetics CYTK:US USD 76.5M 9.65M
Dynavax Technologies DVAX:US USD 244.08M 101.12M
Enanta Pharmaceuticals ENTA:US USD 29.83M 6.79M
Exelixis EXEL:US USD 301.73M 2.79M
Gilead Sciences GILD:US USD 10.42B 1.2B
Halozyme Therapeutics HALO:US USD 109.38M 90.13M
Intercept Pharmaceuticals ICPT:US USD 221.58M 70.16M
Intra Cellular Therapies ITCI:US USD 77.41M 6.78M
IONIS PHARMACEUT IONS:US USD 283.45M 15.64M
Nektar Therapeutics NKTR:US USD 83.99M 21M
Neurocrine Biosciences NBIX:US USD 485.1M 199.4M
Prothena PRTA:US USD 50.6M 10.49M
Regeneron Pharmaceuticals REGN:US USD 2.88B 154.7M
Repligen RGEN:US USD 410.7M 12.83M
Rigel Pharmaceuticals RIGL:US USD 47.26M 7.69M
Sarepta Therapeutics SRPT:US USD 602.92M 57.35M
Teva Pharmaceutical TEVA:IT USD 11.53B 538M
Ultragenyx Pharmaceutical RARE:US USD 227.36M 6.72M
Vertex Pharmaceuticals VRTX:US USD 2.61B 53.1M
Xoma XOMA:US USD 5.42M 3M
YTE INCY:US USD 1.01B 79.92M